KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) Gross Margin (2020 - 2025)

Historic Gross Margin for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to 78.95%.

  • Ginkgo Bioworks Holdings' Gross Margin fell 98400.0% to 78.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 81.66%, marking a year-over-year decrease of 45200.0%. This contributed to the annual value of 83.02% for FY2024, which is 15200.0% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Gross Margin stood at 78.95% for Q3 2025, which was down 98400.0% from 80.97% recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Gross Margin peaked at 102.5% during Q4 2023, and registered a low of 156.28% during Q1 2023.
  • Its 5-year average for Gross Margin is 3.25%, with a median of 9.15% in 2021.
  • Its Gross Margin has fluctuated over the past 5 years, first crashed by -1244400bps in 2023, then skyrocketed by 2320200bps in 2024.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Gross Margin (Quarter) stood at 9.15% in 2021, then plummeted by -1127bps to 112.28% in 2022, then surged by 191bps to 102.5% in 2023, then fell by -19bps to 82.77% in 2024, then decreased by -5bps to 78.95% in 2025.
  • Its Gross Margin stands at 78.95% for Q3 2025, versus 80.97% for Q2 2025 and 83.53% for Q1 2025.